Cargando…

Correction: Altered Bone Development and an Increase in FGF-23 Expression in Enpp1(−/−) Mice

Detalles Bibliográficos
Autores principales:	Mackenzie, Neil Charles Wallace, Zhu, Dongxing, Milne, Elspeth M., van 't Hof, Rob, Martin, Aline, Quarles, Darryl Leigh, Millán, José Luis, Farquharson, Colin, MacRae, Vicky Elisabeth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3378674/ http://dx.doi.org/10.1371/annotation/8f71d7e8-d81d-4878-bf14-79a313a7810b

Ejemplares similares

Altered Bone Development and an Increase in FGF-23 Expression in Enpp1(−/−) Mice
por: Mackenzie, Neil Charles Wallace, et al.
Publicado: (2012)

The Appearance and Modulation of Osteocyte Marker Expression during Calcification of Vascular Smooth Muscle Cells
por: Zhu, Dongxing, et al.
Publicado: (2011)

Mechanisms and Clinical Consequences of Vascular Calcification
por: Zhu, Dongxing, et al.
Publicado: (2012)

Effects of etidronate on the Enpp1(−/−) mouse model of generalized arterial calcification of infancy
por: HUESA, CARMEN, et al.
Publicado: (2015)

BMP-9 regulates the osteoblastic differentiation and calcification of vascular smooth muscle cells through an ALK1 mediated pathway
por: Zhu, Dongxing, et al.
Publicado: (2015)

Osteocyte-Specific Deletion of Fgfr1 Suppresses FGF23
por: Xiao, Zhousheng, et al.
Publicado: (2014)

Suppressor of cytokine signaling 2 (Socs2) deletion protects bone health of mice with DSS-induced inflammatory bowel disease
por: Dobie, Ross, et al.
Publicado: (2018)

Deficiency of the bone mineralization inhibitor NPP1 protects mice against obesity and diabetes
por: Huesa, Carmen, et al.
Publicado: (2014)

Mineralisation of collagen rich soft tissues and osteocyte lacunae in Enpp1(−/−) mice
por: Hajjawi, Mark O.R., et al.
Publicado: (2014)

A Comparative Transcriptome Analysis Identifying FGF23 Regulated Genes in the Kidney of a Mouse CKD Model
por: Dai, Bing, et al.
Publicado: (2012)

Ablation of Enpp6 Results in Transient Bone Hypomineralization
por: Dillon, Scott, et al.
Publicado: (2020)

FGF-23 Deficiency Impairs Hippocampal-Dependent Cognitive Function
por: Laszczyk, Ann M., et al.
Publicado: (2019)

Increased PHOSPHO1 expression mediates cortical bone mineral density in renal osteodystrophy
por: Hsu, Shun-Neng, et al.
Publicado: (2022)

Isolation and Characterization of Primary Rat Valve Interstitial Cells: A New Model to Study Aortic Valve Calcification
por: Lin, Cui, et al.
Publicado: (2017)

FGF-23 serum levels and bone histomorphometric results in adult patients with chronic kidney disease on dialysis
por: Lima, Florence, et al.
Publicado: (2014)

Deletion of the Pyrophosphate Generating Enzyme ENPP1 Rescues Craniofacial Abnormalities in the TNAP(−/−) Mouse Model of Hypophosphatasia and Reveals FGF23 as a Marker of Phenotype Severity
por: Nam, Hwa Kyung, et al.
Publicado: (2022)

Culture of Murine Embryonic Metatarsals: A Physiological Model of Endochondral Ossification
por: Houston, Dean A., et al.
Publicado: (2016)

End stage renal disease‐induced hypercalcemia may promote aortic valve calcification via Annexin VI enrichment of valve interstitial cell derived‐matrix vesicles
por: Cui, Lin, et al.
Publicado: (2017)

Assessment of 24,25(OH)2D levels does not support FGF23-mediated catabolism of vitamin D metabolites
por: Dai, Bing, et al.
Publicado: (2012)

A computationally identified compound antagonizes excess FGF-23 signaling in renal tubules and a mouse model of hypophosphatemia
por: Xiao, Zhousheng, et al.
Publicado: (2016)

A New Enpp1 allele, Enpp1(ttw-Ham), Identified in an ICR Closed Colony
por: Takabayashi, Shuji, et al.
Publicado: (2014)

Role of ENPP1 on Adipocyte Maturation
por: Liang, Jian, et al.
Publicado: (2007)

ENPP2 Methylation in Health and Cancer
por: Panagopoulou, Maria, et al.
Publicado: (2021)

ENPP1, an Old Enzyme with New Functions, and Small Molecule Inhibitors—A STING in the Tale of ENPP1
por: Onyedibe, Kenneth I., et al.
Publicado: (2019)

Phosphate and FGF-23
por: Jüppner, Harald
Publicado: (2011)

FGF23 and inflammation
por: Sharaf El Din, Usama A A, et al.
Publicado: (2017)

ENPP1 Immunobiology as a Therapeutic Target
por: Ruiz-Fernández de Córdoba, Borja, et al.
Publicado: (2023)

Direct stimulation of bone mass by increased GH signalling in the osteoblasts of Socs2(−/−) mice
por: Dobie, R, et al.
Publicado: (2014)

Role of Fibroblast Growth Factor-23 in Innate Immune Responses
por: Fitzpatrick, Elizabeth A., et al.
Publicado: (2018)

Increased linear bone growth by GH in the absence of SOCS2 is independent of IGF‐1
por: Dobie, Ross, et al.
Publicado: (2015)

Hydrolysis of 2′3′-cGAMP by ENPP1 and design of non-hydrolyzable analogs
por: Li, Lingyin, et al.
Publicado: (2014)

FGF-23 in bone biology
por: Wesseling-Perry, Katherine
Publicado: (2009)

FGF23, Biomarker or Target?
por: Rodelo-Haad, Cristian, et al.
Publicado: (2019)

Pleiotropic Actions of FGF23
por: Erben, Reinhold G.
Publicado: (2017)

Variation in the fibroblast growth factor 23 (FGF23) gene associates with serum FGF23 and bone strength in infants
por: Enlund-Cerullo, Maria, et al.
Publicado: (2023)

ENPP1 processes protein ADP‐ribosylation in vitro
por: Palazzo, Luca, et al.
Publicado: (2016)

Human Heterozygous ENPP1 Deficiency Is Associated With Early Onset Osteoporosis, a Phenotype Recapitulated in a Mouse Model of Enpp1 Deficiency
por: Oheim, Ralf, et al.
Publicado: (2019)

Azathioprine Has a Deleterious Effect on the Bone Health of Mice with DSS-Induced Inflammatory Bowel Disease
por: Morgan, Stephanie, et al.
Publicado: (2019)

A novel role for the mineralocorticoid receptor in glucocorticoid driven vascular calcification
por: Zhu, Dongxing, et al.
Publicado: (2016)

FGF23 Producing Mesenchymal Tumor
por: Papierska, Lucyna, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_hh3d33mgrpqe6almfm7cp5j46e